Skip to main content
. Author manuscript; available in PMC: 2021 Dec 10.
Published in final edited form as: Genet Med. 2021 Jun 10;23(10):1889–1900. doi: 10.1038/s41436-021-01216-8

Table 1.

Summary of clinical information from each proband

Proband 1 Proband 2 Proband 3 Proband 4 Proband 5 Proband 6
Human Variant Y336* Q147Gfs*82 T319Nfs*5 N94Rfs*47 R295P E306K
Inheritance Pattern De novo Autosomal Dominant De novo Autosomal Dominant De novo De Novo
Age of Onset (y/o) 1 month 0 3 0 0 2 months
Current Age (y/o) 32 17 8 15 months 11 12
Sex Male Female Male Male Male Female
Intellectual Disability + + NA + 3/5
Developmental Delay + + + + + 5/6
Seizures + +b + +c 4/6
Neurological Abnormalities + + + + + + 6/6
Visual Disorders + + + + 4/6
Hearing Disorders + + + 3/6
Craniofacial Abnormalities + +a + + + 5/6
Palate Abnormalities + +a + 3/6
Vertebral Abnormalities + + + + + 5/6
Scoliosis + + + 3/6
Toe Abnormalities + +a + 3/6
Connective Tissue Abnormalities + + + 3/6
Cardiac Abnormalities + +a + 3/6
Aortic Dilation + + 2/6

Summary of clinical information from each proband; detailed reports can be found in the supplemental materials. Proband 2 inherited the variant from her mother who has a milder phenotypic presentation. These phenotypes are indicated with an a. Proband 4 inherited his variant from his father, the father did not report any shared phenotypes. It is not known if the mother of proband 2 or father of proband 4 is mosaic.

b

For proband 3 absence seizures were also reported in a sister who did not carry a variant in GDF11.

c

For proband 5 seizures are likely due to Aicardi-Goutieres type 6.